Helping medical device Sponsors improve healthcare since 1967, NAMSA is the only 100% medical device-focused, full continuum Contract Research Organization (CRO). Driven by our global regulatory expertise and in-depth therapeutic knowledge, NAMSA is dedicated to accelerating medical device product development, offering only the most proven solutions to move clients’ products through the development lifecycle efficiently and cost-effectively. From medical device testing; regulatory, reimbursement and quality consulting; and clinical research services, we are the industry’s premier, trusted partner for successful development and commercialization outcomes. Learn more: namsa.com.
Location: United States, Ohio, Toledo
Employees: 1001-5000
Phone: +1 866-666-9455
Founded date: 1967
Investors 2
| Date | Name | Website |
| - | ArchiMed | archimed-g... |
| - | ArchiMed | archimed.g... |
Mentions in press and media 11
| Date | Title | Description |
| 10.09.2024 | Millstone Medical Expands Business Development Team with Key Industry Hires further strengthening its commitment to excellence and innovation in the med device industry | FALL RIVER, Mass., Sept. 10, 2024 /PRNewswire/ -- Millstone Medical Outsourcing, a leading provider of comprehensive post-manufacturing services to the medical device industry, is pleased to announce the expansion of its Business Developmen... |
| 29.08.2024 | DPC Dash Ltd: A Slice of Success in the Chinese Pizza Market | DPC Dash Ltd, the exclusive master franchisee of Domino's Pizza in mainland China, Hong Kong, and Macau, has recently unveiled its interim financial results for the first half of 2024. The numbers tell a compelling story of growth, resilien... |
| 28.08.2024 | Tigermed Reports 2024 Interim Results | HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecyc... |
| 28.08.2024 | Tigermed Reports 2024 Interim Results | HANGZHOU, China, Aug. 28, 2024 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading provider of clinical research solutions across full lifecyc... |
| 28.03.2023 | NAMSA Expands MedTech Portfolio in Market Intelligence and Customer Research Services through its Acquisition of EU-Based SUAZIO | NAMSA, a world-leading MedTech Contract Research Organization (CRO) offering global end-to-end development services, announced its acquisition of SUAZIO, an EU-based strategic consultancy providing global market research services to medical... |
| 03.03.2022 | Clinical Challenges under the EU MDR, Upcoming Webinar Hosted by Xtalks | Join this webinar to gain practical insights and to participate in an extended Q&A session from featured speakers with expertise from multiple MDR geographies. TORONTO (PRWEB) March 03, 2022 With the European Union (EU) Medical Device R... |
| 11.03.2021 | CORRECTING and REPLACING NAMSA Begins Next Chapter of Growth under Newly Appointed CEO, Dr. Christophe Berthoux | TOLEDO, Ohio--(BUSINESS WIRE)--Mar 11, 2021-- Please replace the release with the following corrected version due to multiple revisions in the fourth paragraph. The updated release reads: NAMSA BEGINS NEXT CHAPTER OF GROWTH UNDER NEWLY APPO... |
| 11.03.2021 | NAMSA Begins Next Chapter of Growth under Newly Appointed CEO, Dr. Christophe Berthoux | TOLEDO, Ohio--(BUSINESS WIRE)--Mar 11, 2021-- NAMSA®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its executive leadership transition plan... |
| 24.03.2020 | Sofia Fund portfolio company Abilitech Medical female founder Angie Conley shares her mission | Female founder Angie Conley shares Abilitech’s mission to restore independence to people who can’t use their arms, through its new assistive technology. |
| 27.09.2011 | Medical device CRO gets Ohio tax credit for lab expansion | The toxicology lab expansion comes as the company expects increased demand from both international and domestic customers. NAMSA specializes in clinical trials and product testing for all types of medical devices. The company employs about ... |
Show more